Skip to content

Sharp – part of UDG Healthcare plc, a global leader in contract packaging clinical supply services, has launched a new Inventory Management System (IMS) to support clinical trial sponsors in managing inventory and supplies.

The new system – named Clinventory – has been designed to provide full visibility of stock levels at investigator sites and tracking product through the supply chain. It ensures that sponsors have a comprehensive, real-time view of their trial.

Using the Clinventory IMS will also create efficiencies for trial sponsors by improving the drug management process by leveraging automation to increase reliability, while reducing the costs associated with manual processes.

Sascha Sonnenberg, Global Head of Business Development at Sharp Clinical said “At Sharp, we are always exploring ways to support our clients’ efforts to create more efficiency and lower the cost of their clinical trials”.

“Clinventory has been designed specifically with those smaller-volume, early stage or open label clinical trials in mind, where a larger, more expensive inventory system might offer an array of functionality that is surplus to needs”.

Key features of the Clinventory IMS include:

  • On-demand study supply information
  • Eliminates the need for manual processes for dispatches and returns
  • Customisable automatic resupply, which can be updated as the study enrolment increases or decreases
  • Temperature excursion tracking with supply release and approval
  • Manual shipment requests for emergency situations.

The system complements Sharp’s Clinteract Interactive Response Technology (IRT) solution, which delivers all the features of Clinventory IMS plus subject enrolment and trial randomisation functionality.

The availability of Clinventory IMS means the company’s clients now have a choice of trial management solutions appropriate to the scale of their trial.

Several of Sharp’s clinical services experts will be presenting a webinar on Choosing the Right Clinical Trial Solution for Distribution and Supply Optimization’ which will explore the difference between IRT and IMS. You can  register for the event, which takes places on 8th September, here:  

About Sharp

Sharp, part of UDG healthcare, is a global leader in advanced clinical supply chain services and contract pharmaceutical packaging.  Offering solutions and support to pharma and biotech clients from phase I trials all the way through to commercialization and rapid launch. The organisation has state-of-the-art facilities in the United States, United Kingdom, Belgium and the Netherlands and over 32 clinical depots globally, covering every region of the world.

Our full complement of integrated services includes: analytical, formulation development, clinical manufacturing & packaging, clinical IRT, blister packaging, bottling, secondary assembly and labelling of injectable presentations, compliance packaging, as well as storage and distribution.  Sharp also offers Qualified Person (QP) services for European distribution.

Through our partnership with Berkshire Sterile Manufacturing we also offer specialist isolator-based filling of vials, syringes, cartridges and containers, as well as lyophilization and terminal sterilization.

For more information on Sharp and its solutions, visit or follow us on LinkedIn, and Twitter.

For further information, images and interview opportunities with Sharp, please contact Matthew Dent at ramarketing | | +34 711 00 80 99


Alison Dillon
Marketing Communications Manager
Tel: +353-87-146-8522

Happy World Environment Day! To mark today, UDG Healthcare officially introduced its Sustainability Champions' Network to employees globally.
#sustainability #environment #worldenvironmentday2021 #ESG

New Manufacturing Site in South Wales to Create 300 New Jobs - Innova Medical Group, has announced an initial investment in South Wales to start producing millions of COVID lateral flow tests per day in the UK. @Sharp_Services

“Wales welcomes Innova’s investment & the 100s of new job opportunities it creates, boosting the local economy & further enhancing Wales’ reputation in the life sciences sector” @vaughangething

More good news & job creation for Wales